Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Core Viewpoint - Sanara MedTech Inc. is set to report its fourth quarter and full year 2024 financial results on March 25, 2025, before the U.S. financial markets open [1] Group 1: Financial Reporting - The company will host a conference call and webcast on March 25, 2025, at 8:00 a.m. Eastern Time to discuss the financial results and hold a Q&A session [2] - A telephonic replay of the conference call will be available until April 8, 2025 [2] Group 2: Company Overview - Sanara MedTech Inc. focuses on developing and commercializing transformative technologies aimed at improving clinical outcomes and reducing healthcare costs in surgical, chronic wound, and skincare markets [4] - The company markets and distributes a range of surgical, wound, and skincare products, primarily in the North American advanced wound care and surgical tissue repair markets [4] - Sanara's product portfolio includes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft, and various advanced biologic products [4] - The company is also involved in telemedicine services for wound care and dermatology consultations [4] - Sanara is actively seeking long-term strategic partnerships to enhance product offerings that improve outcomes at a lower cost [4]